Title : Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis.

Pub. Date : 2021

PMID : 33859780






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Zoledronic Acid Enhanced the Antitumor Effect of Cisplatin on Orthotopic Osteosarcoma by ROS-PI3K/AKT Signaling and Attenuated Osteolysis. Cisplatin AKT serine/threonine kinase 1 Homo sapiens
2 The results showed that in vitro, compared with the single treatment and control, the combination of ZA and cisplatin could significantly inhibit the activity and proliferation of 143B cells and induced their apoptosis and further promoted the generation of ROS and inhibited the phosphorylation of PI3K and AKT. Cisplatin AKT serine/threonine kinase 1 Homo sapiens
3 In conclusion, ZA enhanced the antitumor effect of cisplatin on osteosarcoma by ROS-PI3K/AKT signaling, reducing the chemoresistance and osteoclast activation to enhance chemotherapy and inhibit osteolysis. Cisplatin AKT serine/threonine kinase 1 Homo sapiens